Efavirenz combination potent after 48 weeks.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D003521:Cyclopropanes; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage*; D009930:Organic Chemicals; D010078:Oxazines; D016896:Treatment Outcome
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D009930:Organic Chemicals; D010078:Oxazines; C112033:antiviral 1592; D019469:Indinavir; C098320:efavirenz